ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Highlights Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Market Closed - Hong Kong S.E. Other stock markets 04:08:32 2024-05-29 am EDT			5-day change	1st Jan Change
10.64 ^HKD	-1.12%		+4.72%	-14.47%

May. 09	Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director	CI
Mar. 22	Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	Mar. 22	MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	Mar. 07	MT
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	Mar. 07	MT
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	Mar. 06	CI
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	Feb. 21	CI
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	Jan. 21	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	Dec. 28	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	Dec. 20	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	Dec. 11	CI
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter	Dec. 11	MT
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	Nov. 07	CI
Zylox-Tonbridge Medical Buys Back 1.1 Million Shares	23-10-13	MT
Zylox-Tonbridge Medical Technology Shareholders Approve Buyback Mandate	23-09-27	MT
Zylox-Tonbridge Medical Technology Co., Ltd.'S ZENFlow Tiger? LD PTA Dilatation Catheter Receives ANVISA Marketing Approval	23-08-30	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zylox-Tonbridge Medical Signs Collaboration Deal for Sale of Surgical Guidewire Products in China	23-04-21	MT
Zylox-Tonbridge Medical Technology Shrinks 2022 Loss as Revenue Surges 88%	23-03-29	MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Nmpa Granted Marketing Approval for Zylox Octoplus Retrievable Inferior Vena Cava Filter of Zylox-Tonbridge Medical Technology Co., Ltd	22-12-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Highlights

Filters